TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Maternal and neonatal immunisation service to include Respiratory Syncytial Virus (RSV) vaccinations for pregnant women - "20240901 Dorset Perinatal Imms Team"

Miscellaneous health services
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "Maternal and neonatal immunisation service to include Respiratory Syncytial Virus (RSV) vaccinations for pregnant women - "20240901 Dorset Perinatal Imms Team"". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS EnglandScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
2Bids / Report
28.6% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 17 active published awards; 7 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS England
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published27 Sept 2024, 16:14 BST
Last source update27 Sept 2024, 16:14 BST
Recurring procurementNot published
ClassificationMiscellaneous health services
Delivery area
OCIDocds-h6vhtk-04a3cb
What is being bought
NHS England (South West), have made an urgent award under the Provider Selection Regime, maternal and neonatal immunisation services within Dorset. An urgent award has been made due to unforeseen circumstance not attributable to the relevant authority. Delaying an award in order to conduct a full application of the Regime would pose a risk to patients. These services include Pertussis, Flu and COVID-19 vaccinations for pregnant women, Bacillus Calmette-Guérin (BCG) vaccinations for newborn infants, and the roll out of the Respiratory Syncytial Virus (RSV) vaccination programme for pregnant woman over 28 weeks. Since 2023, the Joint Committee on Vaccination and Immunisation (JCVI) has been actively reviewing the latest evidence on immunisation products which can protect both infants and older adults against RSV infection and disease. In summer 2024, the national RSV vaccination programme was announced. NHS England were made aware of the specific arrangements for RSV immunisation by the Department of Health in June, with contracts needing to start on 1st September 2024. The specific arrangements meant in the Dorset system there would need to be an alternative solution to in-house provision by the acute trusts of this level of vaccines for pregnant women at this stage of pregnancy. The RSV vaccine will be offered throughout the year between 1st September 2024 to 30th August 2025. The total contract value is £250,000.
What changed
From the official release history
  1. Status changed to complete
    27 Sept 2024, 16:14 BST
  2. Official notice release published
    27 Sept 2024, 16:14 BST
  3. Buyer information updated
    27 Sept 2024, 16:14 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    Pertussis, Flu and COVID-19 vaccinations for pregnant women, BCG vaccinations for newborn infants, and the roll out of the RSV programme
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    27 Sept 2024, 16:14 BST
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 1 Sept 2024, 00:00 BST · £250,000
Commercial outcome and competition
Awards
Dorset HealthCare
Not published · Not published · active
Contracts
Contract
£250,000 · signed 1 Sept 2024, 00:00 BST · active
Bid statistics
bids: 1 (lot 1)
Buyer and organisations in this procedure

NHS England

Contracting authority GB-FTS-91619
View buyer profile
  • NHS England
    buyer

    Wellington House, 133-135 Waterloo Road, London, UKI, SE1 8UG
  • Dorset HealthCare
    supplier

    SENTINEL HOUSE 4-6 NUFFIELD ROAD NUFFIELD INDUSTRIAL ESTATE, POOLE, UKK2, BH17 0RB
  • NHS England
    reviewBody

    London
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleNHS England were made aware of the specific arrangements for RSV immunisation by the Department of Health in June with contracts needing to start on 1st September. The specific arrangements meant in the Dorset system there would need to be an alternative solution to in-house provision by the acute trusts of this level of vaccines for pregnant women at this stage of pregnancy. This circumstance was unforseen by the Commissioner, a delay would pose a risk to patient safety and provided insufficent time to run a procurement process. The urgent award will allow for a procurement process to be followed under PSR.